"See-and-treat" loop electrosurgical excision. Has the time come for a reassessment?

J Reprod Med

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Department of Pathology, University of Virginia Health Sciences System, Box 800712, Charlottesville, VA 22908, USA.

Published: July 2002

Objective: To review the results of a policy decision to offer selected women with cervical high grade squamous intraepithelial lesions (HSILs) loop electrosurgical excision (LEEP) at the time of their initial colposcopic evaluation.

Study Design: Sixty-one patients with newly diagnosed cytologic cervical HSIL were evaluated for inclusion in a "see-and-treat" protocol. Fifty of these patients met inclusion criteria and underwent immediate loop excision of the cervical transformation zone at their initial colposcopic visit.

Results: Forty-eight of 50 patients that underwent see-and-treat management at their initial colposcopic evaluation had histologic evidence of cervical dysplasia/neoplasia. The positive predictive value of diagnostic colposcopy in this setting was 96%, with a 95% confidence interval (88-99%). Two patients had no pathologic abnormality, for an overtreatment incidence of 4%.

Conclusion: The selected use of see-and-treat management of cytologic cervical HSIL is feasible, highly predictive and associated with an extremely low incidence of overtreatment. Such management has the potential to increase patient satisfaction and compliance while drastically reducing health care dollars currently directed toward the management of HSIL. Strong consideration should be given to accepting see-and-treat management as a viable alternative in the care of patients with documented cervical cytologic HSIL.

Download full-text PDF

Source

Publication Analysis

Top Keywords

initial colposcopic
12
see-and-treat management
12
loop electrosurgical
8
electrosurgical excision
8
cytologic cervical
8
cervical hsil
8
cervical
6
patients
5
management
5
"see-and-treat" loop
4

Similar Publications

Objective: This study aims to analyze factors associated with the missed diagnosis of high-grade squamous intraepithelial lesions (HSIL+) in patients initially diagnosed with low-grade squamous intraepithelial lesions (LSIL) through colposcopic biopsy and to develop a predictive model for assessing the risk of missed HSIL+.

Methods: We conducted a retrospective analysis of 505 patients who underwent loop electrical excision procedure (LEEP) following an LSIL diagnosis by colposcopic biopsy. Logistic regression was used to identify demographic and pathological parameters associated with missed diagnoses of HSIL+.

View Article and Find Full Text PDF
Article Synopsis
  • Vaccination against HPV helps lower the rates of HPV-related health issues globally, especially as young people start sexual activity earlier.
  • With many women delaying motherhood, there’s a growing concern that certain treatments for HPV-related lesions could create complications during childbirth, highlighting the need for careful diagnostic tools.
  • Methylation testing shows promise in avoiding unnecessary surgeries for low-grade lesions, proving beneficial in identifying high-grade lesions and potentially aiding in cervical cancer screenings.
View Article and Find Full Text PDF
Article Synopsis
  • The study aims to evaluate the clinical outcomes of a second surgical procedure combining LEEP and transcervical resection in patients with positive endocervical margins after initial LEEP for high-grade cervical lesions.
  • A total of 67 patients participated, including those with high-grade squamous intraepithelial lesions (HSIL) and adenocarcinoma in situ (AIS), with follow-up on cytological exams and HPV testing to assess the effectiveness of the second surgeries.
  • Results showed a 24% residual HSIL rate and 29% of HSIL patients still had positive margins after the second procedure, highlighting the challenges in completely removing high-grade lesions.
View Article and Find Full Text PDF

Automated analysis of digital medical images in cervical cancer screening: A systematic review.

medRxiv

September 2024

Division of Biomedical Engineering, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, Western Cape, South Africa.

Article Synopsis
  • Cervical cancer screening in low- and middle-income countries (LMICs) faces challenges due to a lack of specialists and costly diagnostic tools, prompting researchers to create low-cost portable devices and automate image analysis for better decision-making.
  • A systematic review was conducted to evaluate the range of automated technology systems used for cervical cancer screening, resulting in 17 studies using mobile device images and 56 studies using conventional devices.
  • The findings show that computer-aided diagnostics (CAD) outperform manual analysis in accuracy, but the clinical validation of these novel devices is still insufficient in LMICs where they are most needed.
View Article and Find Full Text PDF

Background/aim: In the past, the standard of care for women with abnormal cervical cytology has been the performance of colposcopically guided biopsy, followed by conization or large loop excision of the transition zone (LLETZ) where biopsy revealed pre-cancerous or cancerous areas. More straightforward protocols are emerging which advocate performing LLETZ in all women with highly suspicious cytology, suspicious colposcopic impression, or the presence of high-risk oncogenic human papilloma virus (HPV) strains in their cervical swabs. This, theoretically, would reduce the rate of false-negative diagnoses, but at the price of overtreating a significant number of healthy women.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!